Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimpei Eguchi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|January 24, 2023
Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancerRyota Tanaka, Shimpei Eguchi, Kenjiro Kimura, et al.
BMC Cancer|July 8, 2022
Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell lineRyota Tanaka, Kenjiro Kimura, Shimpei Eguchi, et al.
Anticancer Research|August 1, 2025
Interleukin-6 Secreted from Cancer-associated Fibroblast Inhibits Cancer Growth in Biliary Tract CancerNaoki Tani, Shimpei Eguchi, Kenjiro Kimura, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 29, 2025
Risk assessment for loss of independence after hepatopancreaticobiliary surgery in the elderly: a prospective multicenter studyTakahito Kawaguchi, Shogo Tanaka, Masao Ogawa, et al.
Anticancer Research|April 30, 2022
Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to SuccessShimpei Eguchi, Kenjiro Kimura, Ken Kageyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2022
[A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal Cancer]Gen Tsujio, Kazuya Muguruma, Shimpei Eguchi, et al.
World Journal of Surgery|October 20, 2021
Prognostic Factors and Lymph Node Metastasis Patterns of Primary Duodenal CancerKohei Nishio, Kenjiro Kimura, Shimpei Eguchi, et al.
Clinical Journal of Gastroenterology|April 3, 2021
Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case reportShimpei Eguchi, Hiroji Shinkawa, Yasunori Sato, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 28, 2020
Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for HepatolithiasisToru Miyazaki, Hiroji Shinkawa, Shigekazu Takemura, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|January 24, 2023
Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancerRyota Tanaka, Shimpei Eguchi, Kenjiro Kimura, et al.
BMC Cancer|July 8, 2022
Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell lineRyota Tanaka, Kenjiro Kimura, Shimpei Eguchi, et al.
Anticancer Research|August 1, 2025
Interleukin-6 Secreted from Cancer-associated Fibroblast Inhibits Cancer Growth in Biliary Tract CancerNaoki Tani, Shimpei Eguchi, Kenjiro Kimura, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 29, 2025
Risk assessment for loss of independence after hepatopancreaticobiliary surgery in the elderly: a prospective multicenter studyTakahito Kawaguchi, Shogo Tanaka, Masao Ogawa, et al.
Anticancer Research|April 30, 2022
Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to SuccessShimpei Eguchi, Kenjiro Kimura, Ken Kageyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2022
[A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal Cancer]Gen Tsujio, Kazuya Muguruma, Shimpei Eguchi, et al.
World Journal of Surgery|October 20, 2021
Prognostic Factors and Lymph Node Metastasis Patterns of Primary Duodenal CancerKohei Nishio, Kenjiro Kimura, Shimpei Eguchi, et al.
Clinical Journal of Gastroenterology|April 3, 2021
Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case reportShimpei Eguchi, Hiroji Shinkawa, Yasunori Sato, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 28, 2020
Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for HepatolithiasisToru Miyazaki, Hiroji Shinkawa, Shigekazu Takemura, et al.
Pageof 1